Renub Research has announced the addition of the " Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global" report to its offering Cancer Testing Market – Key Facts Covered • Cancer is the second-leading cause of death and disability in the world, behind only heart disease. • Asia has the highest number of new brain cases, new lung cancer cases and new liver cancer cases in the world. While, Europe has the highest number of kidney cancer incidence. Americas has the highest number of prostate cases. (Complete figure from 2009 – 2018 is given in the report) • In the global cancer testing market, Fish technology accounts for majority of the market share. (Complete figure from 2011 – 2018 is given in the report) • Breast cancer is the leading cancer market in 2012 followed by Cervical Cancer. (Complete figure from 2010 – 2018 is given in the report) • In the cancer testing market, the Pharmacognostic Histology, Flow Cytometry and Serum based cancer marker stands at the second, third and fourth position in 2012. (Complete figure from 2011 – 2018 is given in the report) • Europe has the highest number of bladder cases in 2009. (Complete figure from 2011 – 2018 is given in the report) • Asia, Americas and Europe are the top region in the breast cancer incidence in the world in the respective order. (Complete figure from 2011 – 2018 is given in the report) • Asia has more than 50% of the worldwide new cervix cancer cases and this trend is likely to continue till the forecasting period 2020. Renub Research study titled “Cancer Test Market & Forecast, Companies Cancer Test Platform, Pipeline Analysis and Clinical Trials - Global” provides a comprehensive assessment of the fast-evolving, high-growth of Cancer Test market segment. This 277 page report with 52 Figures and 57 Tables studies the Cancer Test Platform of 20 Companies. This report is broadly divided into 8 chapters. A. Global – Cancer Testing Market and New Cases (Chapter 2) B. Global – Cancer Testing Market Share & Forecast (Chapter 3) C. Global – Segment Wise Cancer Testing Market & Forecast (Chapter 4) D. Global – Organ Specific Cancer Testing Market & Forecast (Chapter 5) E. Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter 6) F. Geographic Region – Number of New Cancer Cases (Chapter 7) G. Number of New Cancer Cases by Site - Geographic Region Distribution & Clinical Trials (Chapter 8) Global – Segment Wise Cancer Testing Market (To 2018) (Chapter No. 4) • Prostate Specific Antigen (PSA) Test Market & Forecast • Fecal Occult Blood Test Market & Forecast • Fluorescent In-Situ Hybridization (FISH) Test Market & Forecast • Human Papilloma Virus (HPV) Test Market & Forecast • Bladder Test Market & Forecast • Serum Based Cancer Markers Market & Forecast • Pharmacognostic Histology Market & Forecast • Flow Cytometry Market & Forecast • Other Test Market & Forecast Global – Organ Specific Cancer Testing Market (To 2018) (Chapter No. 5) • Bladder Cancer Test Market & Forecast • Breast Cancer Test Market & Forecast • Cervical Cancer Test Market & Forecast • Colorectal (Colon) Cancer Test Market & Forecast • Ovarian Cancer Test Market & Forecast • Prostate Cancer Test Market & Forecast • Liver Cancer Test Market & Forecast • Flow Cytometry Market & Forecast • Other Organ Specific Cancer Test Market & Forecast Cancer Diagnostics – Companies Novel Test Platform Analysis (Chapter No. 6) 1. Abbott 2. Radient Pharmaceuticals 3. BD Diagnostics 4. Beckman Coulter, Inc. 5. BioCurex 6. bioMerieux 7. Cepheid 8. CytoCore Inc. 9. DiagnoCure, Inc 10. Gen-Probe, Inc. 11. Genomic Health Inc 12. QIAGEN Marseille (Earlier Ipsogen) 13. Myriad Genetics, Inc 14. Panacea Pharmaceuticals, Inc. 15. Qiagen 16. Siemens Heathcare Diagnostics 17. Roche 18. Ventana Medical Systems 19. Trovagene Inc 20. Vermillion, Inc Geographic Region – Number of New Cancer Cases (To 2020) (Chapter No. 7) 1. Africa 2. Americas 3. Asia 4. Europe 5. Oceania Number of New Cancer Cases by Site - Geographic Region Distribution (To 2020) (Chapter 8) 1. Bladder Cancer 2. Brain Cancer 3. Breast Cancer 4. Cervix Cancer 5. Colorectal Cancer 6. Corpus Cancer 7. Hodgkin’s Lymphoma 8. Kaposi Sarcoma 9. Kidney Cancer 10. Larynx Cancer 11. Leukaemia 12. Liver Cancer 13. Lung Cancer 14. Melanoma 15. Myeloma 16. Nasopharynx 17. Non-Hodgkin Lymphoma 18. Oesophagus 19. Oral Cavity 20. Other Pharynx 21. Ovary Cancer 22. Pancreas Cancer 23. Prostate Cancer 24. Stomach Cancer 25. Testis Cancer 26. Thyroid Cancer 27. Other Sites Cancer Site - Clinical Trials (Chapter 8) 1. Bladder Cancer 2. Cervical Cancer 3. Colorectal Cancer 4. Liver Cancer 5. Ovarian Cancer 6. Prostate Cancer Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases. Click here to view the report details:http://www.renub.com/report/cancer-test-market-forecast-companies-cancer-test-platform-pipeline-analysis-and-clinical-trials---global-125 For more information visit: http://www.renub.com/ Contact Us Rajat Gupta Sr. Manager Sales & Marketing Div Renub Research Email: This email address is being protected from spambots. You need JavaScript enabled to view it. Phone: Phone: +1-678-302-0700 (USA), +91-120-421-9822, +91-120-254-5750 (India) Web: http://www.renub.com

Share It!

Featured

release-news.com Webutation